SCHEMBL28857692

SCHEMBL28857692

O=[C]CCC(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
EPHX1 P07099 2/20 0.41
ALPI P09923 1/20 0.39
PKM P14618 1/20 0.39
PTGS1 P23219 1/20 0.39
XIAP P98170 1/20 0.39
SLC7A5 Q01650 1/20 0.39
CPA3 P15088 2/20 0.39
SLC6A2 P23975 2/20 0.39
TAAR1 Q96RJ0 2/20 0.39
MAOA P21397 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
CYP2A6 P11509 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MDM2 Q00987 1/20 0.38
LAP3 P28838 3/20 0.37
ANPEP P15144 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2877114 0.84 LAP3 (0.36) CYP1A2SLC6A2TAAR1MAOASLC6A4
SCHEMBL6946871 0.80 CYP1A2 (0.39) CYP1A2EPHX1ALPIPKMPTGS1
SCHEMBL9725521 0.80 TAAR1 (0.45) CYP1A2SLC6A2TAAR1MAOASLC6A4
SCHEMBL6441941 0.77 EPHX1 (0.52) CYP1A2EPHX1ALPIPKMPTGS1
SCHEMBL19812645 0.76 EPHX1 (0.43) CYP1A2EPHX1ALPIPKMPTGS1
SCHEMBL367322 0.76 LAP3 (0.38) CYP1A2EPHX1SLC6A2TAAR1MAOA
SCHEMBL4981467 0.74 EPHX1 (0.60) CYP1A2EPHX1ALPIPKMPTGS1
SCHEMBL7864719 0.73 TAAR1 (0.42) CYP1A2SLC6A2TAAR1MAOASLC6A4
SCHEMBL24108632 0.73 EPHX1 (0.48) CYP1A2EPHX1SLC6A2TAAR1MAOA
SCHEMBL7085691 0.73 EPHX1 (0.48) EPHX1SLC6A2TAAR1MAOASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107802623-A For the bone related disease of EP4 mediations and the difluoro lactam composition of illness 开曼化学股份有限公司 2018-03-16 CN disclosed